Arkolith/Insider Trading/PBLA/Form 4

Schemel Donald Robert

Director, 10% OwnerPanbela Therapeutics, Inc. (PBLA) · full profile →Form 4 · filed May 27, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2021Grant(A)4K—$097K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2021Grant(A)12K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-21-013594) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML